Pay vs Performance Disclosure
|
5 Months Ended |
7 Months Ended |
12 Months Ended |
Oct. 11, 2022 |
Apr. 29, 2023 |
Apr. 29, 2023
USD ($)
$ / shares
|
Apr. 30, 2022
USD ($)
$ / shares
|
Apr. 24, 2021
USD ($)
$ / shares
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Pay vs Performance [Table Text Block] |
|
|
Pay Versus Performance
As a result of the rules adopted by the Securities and Exchange Commission under
Dodd-Frank and Item 402(v) of Regulation S-K (“PvP Rules”), we are providing the following information about the relationship between “compensation actually paid” to our CEO (referred to below as our Principal Executive Officer or PEO) and
average “compensation actually paid” to our other named executive officers (“Non-PEO NEOs”) and certain metrics of our financial performance for the last three years, in each case, calculated in accordance with the PvP Rules. For purposes of
this disclosure, “compensation actually paid” or “CAP” to our PEO and Non-PEO NEOs represents an amount calculated based on the Securities and Exchange Commission’s prescribed formula. CAP is not compensation actually earned by or paid to our
NEOs in each respective year.
Pay Versus Performance Table
|
2023
|
|
|
$5,540,867
|
|
|
$3,667,482
|
|
|
$6,074,640
|
|
|
($7,551,398)
|
|
|
$1,416,731
|
|
|
$670,895
|
|
|
$197.07
|
|
|
$139.89
|
|
|
$136.20
|
|
|
$206.6
|
|
|
$2.42
|
|
|
2022
|
|
|
—
|
|
|
—
|
|
|
$7,142,343
|
|
|
$4,514,488
|
|
|
$1,783,376
|
|
|
$1,342,942
|
|
|
$215.55
|
|
|
$134.30
|
|
|
$130.95
|
|
|
$201.7
|
|
|
$2.09
|
|
|
2021
|
|
|
—
|
|
|
—
|
|
|
$4,757,845
|
|
|
$17,291,216
|
|
|
$1,347,273
|
|
|
$4,100,888
|
|
|
$226.65
|
|
|
$125.41
|
|
|
$127.38
|
|
|
$155.1
|
|
|
$1.91
|
|
(1)
|
The dollar amounts reported in this column represent the CAP to our current PEO, Mr. Zurbay, as computed in accordance with PvP Rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. Zurbay during the
applicable year. In accordance with the PvP Rules, adjustments were made to Mr. Zurbay’s total compensation to determine the CAP as shown in the Adjustment Tables below.
|
(2)
|
The dollar amounts reported in this column represent the CAP to our former PEO, Mr. Walchirk, as computed in accordance with PvP Rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. Walchirk
during the applicable year. In accordance with the PvP Rules, adjustments were made to Mr. Walchirk’s total compensation to determine the CAP as shown in the Adjustment Tables below.
|
(3)
|
The dollar amounts reported in this column represent the CAP to our Non-PEO NEOs as a group, as computed in accordance with PvP
Rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the Non-PEO NEOs as a group during the applicable year. In accordance with the PvP Rules, adjustments were made to our Non-PEO NEOs’ total
compensation to determine the CAP as shown in the Adjustment Tables below. Our Non-PEO NEOs in fiscal 2023 were Messrs. Barry, Pohlman, Korsh and Rogan and Ms. Frohning. Our Non-PEO NEOs in fiscal 2022 were Messrs. Zurbay, Pohlman and
Korsh and Ms. Frohning. Our Non-PEO NEOs in fiscal 2021 were Messrs. Zurbay, Pohlman, Korsh and Shirley.
|
(4)
|
Cumulative shareholder returns reflect $100 invested as of market close on April 24, 2020, the final trading day of our company’s
fiscal year ended April 25, 2020 (“fiscal 2020”).
|
(5)
|
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the
beginning of each period for which a return is indicated. The peer group used for this purpose is the S&P 500 Healthcare Index.
|
(6)
|
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the
beginning of each period for which a return is indicated. The peer group used for this purpose is the Dow Jones U.S. Health Care Index.
|
(7)
|
Reflects the Company’s selected measure of adjusted EPS for each respective year as disclosed in the Compensation Discussion and
Analysis for each year’s proxy statement, with such adjustments as described in the applicable Compensation Discussion and Analysis.
|
|
|
|
Company Selected Measure Name |
|
|
Adjusted EPS
|
|
|
Named Executive Officers, Footnote [Text Block] |
|
|
(3)
|
The dollar amounts reported in this column represent the CAP to our Non-PEO NEOs as a group, as computed in accordance with PvP
Rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the Non-PEO NEOs as a group during the applicable year. In accordance with the PvP Rules, adjustments were made to our Non-PEO NEOs’ total
compensation to determine the CAP as shown in the Adjustment Tables below. Our Non-PEO NEOs in fiscal 2023 were Messrs. Barry, Pohlman, Korsh and Rogan and Ms. Frohning. Our Non-PEO NEOs in fiscal 2022 were Messrs. Zurbay, Pohlman and
Korsh and Ms. Frohning. Our Non-PEO NEOs in fiscal 2021 were Messrs. Zurbay, Pohlman, Korsh and Shirley.
|
|
|
|
Peer Group Issuers, Footnote [Text Block] |
|
|
(5)
|
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the
beginning of each period for which a return is indicated. The peer group used for this purpose is the S&P 500 Healthcare Index.
|
(6)
|
Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the
beginning of each period for which a return is indicated. The peer group used for this purpose is the Dow Jones U.S. Health Care Index.
|
|
|
|
Adjustment To PEO Compensation, Footnote [Text Block] |
|
|
The following table sets forth adjustments from the Summary Compensation Table (“SCT”) to
CAP to our current PEO, Mr. Zurbay. Mr. Zurbay served as our PEO for a portion of fiscal 2023.
|
2023
|
|
|
$5,540,867
|
|
|
($3,889,123)
|
|
|
$3,113,226
|
|
|
($1,062,922)
|
|
|
($34,566)
|
|
|
—
|
|
|
$3,667,482
|
|
|
2022
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2021
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
(1)
|
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards”
columns in the SCT for the applicable year.
|
(2)
|
The equity award adjustments for each applicable year to calculate the CAP include the addition (or subtraction, as applicable) of
the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of
the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal
to the change as of the vesting date (from the end of the prior fiscal year) in fair value; and (iv) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a
deduction for the amount equal to the fair value at the end of the prior fiscal year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The following adjustments
are not applicable for any of the Adjustment Tables and are therefore omitted: (i) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; and (ii) the dollar value of any dividends or other
earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
We had neither changes in the actuarial present value of pension benefits nor pension benefit adjustments.
|
The following table sets forth adjustments from the SCT to CAP to our former PEO,
Mr. Walchirk. Mr. Walchirk served as our PEO for a portion of fiscal 2023 and he was our only PEO for fiscal 2022 and fiscal 2021.
|
2023
|
|
|
$6,074,640
|
|
|
($5,323,127)
|
|
|
—
|
|
|
—
|
|
|
($107,722)
|
|
|
($8,195,189)
|
|
|
($7,551,398)
|
|
|
2022
|
|
|
$7,142,343
|
|
|
($4,703,083)
|
|
|
$4,366,883
|
|
|
($1,798,226)
|
|
|
($493,429)
|
|
|
—
|
|
|
$4,514,488
|
|
|
2021
|
|
|
$4,757,845
|
|
|
($2,181,598)
|
|
|
$6,938,194
|
|
|
$6,059,476
|
|
|
$1,717,299
|
|
|
—
|
|
|
$17,291,216
|
|
(1)
|
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards”
columns in the SCT for the applicable year.
|
(2)
|
The equity award adjustments for each applicable year to calculate the CAP include the addition (or subtraction, as applicable) of
the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of
the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal
to the change as of the vesting date (from the end of the prior fiscal year) in fair value; and (iv) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a
deduction for the amount equal to the fair value at the end of the prior fiscal year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The following adjustments
are not applicable for any of the Adjustment Tables and are therefore omitted: (i) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; and (ii) the dollar value of any dividends or other
earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
We had neither changes in the actuarial present value of pension benefits nor pension benefit adjustments.
|
|
|
|
Non-PEO NEO Average Total Compensation Amount |
|
|
$ 1,416,731
|
$ 1,783,376
|
$ 1,347,273
|
Non-PEO NEO Average Compensation Actually Paid Amount |
|
|
$ 670,895
|
1,342,942
|
4,100,888
|
Adjustment to Non-PEO NEO Compensation Footnote [Text Block] |
|
|
The following table sets forth adjustments from the average SCT to the average amount of
CAP to our Non-PEO NEOs.
|
2023
|
|
|
$1,416,731
|
|
|
($723,144)
|
|
|
$438,869
|
|
|
($239,944)
|
|
|
($12,003)
|
|
|
($209,614)
|
|
|
$670,895
|
|
|
2022
|
|
|
$1,783,376
|
|
|
($852,067)
|
|
|
$791,512
|
|
|
($324,290)
|
|
|
($55,589)
|
|
|
—
|
|
|
$1,342,942
|
|
|
2021
|
|
|
$1,347,273
|
|
|
($402,747)
|
|
|
$1,279,702
|
|
|
$1,564,227
|
|
|
$312,433
|
|
|
—
|
|
|
$4,100,888
|
|
(1)
|
The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards”
columns in the SCT for the applicable year.
|
(2)
|
The equity award adjustments for each applicable year to calculate the CAP include the addition (or subtraction, as applicable) of
the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of
the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal
to the change as of the vesting date (from the end of the prior fiscal year) in fair value; and (iv) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a
deduction for the amount equal to the fair value at the end of the prior fiscal year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The following adjustments
are not applicable for any of the Adjustment Tables and are therefore omitted: (i) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; and (ii) the dollar value of any dividends or other
earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year.
We had neither changes in the actuarial present value of pension benefits nor pension benefit adjustments.
|
|
|
|
Compensation Actually Paid vs. Total Shareholder Return [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our TSR during fiscal years 2021 through 2023 versus the Dow Jones U.S. Health Care Index and the S&P 500 Healthcare Index. We have presented both of these indices given our transition from the S&P 500 Healthcare Index to
the Dow Jones U.S. Health Care Index. In each of the following charts, “PEO” represents Mr. Walchirk and “PEO 2” represents Mr. Zurbay.
|
|
|
Compensation Actually Paid vs. Net Income [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our net income during fiscal years 2021 through 2023.
|
|
|
Compensation Actually Paid vs. Company Selected Measure [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our adjusted EPS, our primary company-selected measure, during fiscal years 2021 through 2023.
|
|
|
Total Shareholder Return Vs Peer Group [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our TSR during fiscal years 2021 through 2023 versus the Dow Jones U.S. Health Care Index and the S&P 500 Healthcare Index. We have presented both of these indices given our transition from the S&P 500 Healthcare Index to
the Dow Jones U.S. Health Care Index. In each of the following charts, “PEO” represents Mr. Walchirk and “PEO 2” represents Mr. Zurbay.
|
|
|
Tabular List [Table Text Block] |
|
|
List of Most Important Financial Measures
The following list sets forth financial performance measures that we considered to be the
most important in how CAP was linked to our company performance during fiscal 2023.
For each year disclosed in our Compensation Discussion and Analysis, adjusted earnings
per share is used in our long-term incentive program. Our Compensation and Human Capital Committee determined that this structure maintains management’s focus on execution while preserving a multi-year performance measurement period. The
committee believes this incentive framework is strongly aligned with shareholder interests and is consistent with shareholder feedback. Adjusted earnings per share is a non-GAAP financial metric. See the reconciliation of GAAP to non-GAAP
financial measures table, which appears as Annex A to this proxy statement, for further information regarding our adjusted financial metrics.
•
|
Adjusted Operating Income
|
For each year disclosed in our Compensation Discussion and Analysis, adjusted operating
income is used in our short-term incentive program. Our Compensation and Human Capital Committee determined that this structure drives performance and incentivizes management. The committee believes this incentive framework is strongly aligned
with shareholder interests and is consistent with shareholder feedback. Adjusted operating income is a non-GAAP financial metric. See the reconciliation of GAAP to non-GAAP financial measures table, which appears as Annex A to this proxy statement, for further information regarding our adjusted financial metrics.
For each year disclosed in our Compensation Discussion and Analysis, free cash flow is
used in our short-term incentive program. Our Compensation and Human Capital Committee determined that this structure drives performance and incentivizes management. The committee believes this incentive framework is strongly aligned with
shareholder interests and is consistent with shareholder feedback. We define free cash flow as net cash used in operating activities less capital expenditures plus the collection of deferred purchase price receivables. See the free cash flow
disclosures, which appear on Annex A to this proxy statement, for further information.
|
|
|
Total Shareholder Return Amount |
|
|
$ 197.07
|
215.55
|
226.65
|
Peer Group Total Shareholder Return Amount |
|
|
139.89
|
134.3
|
125.41
|
Peer Group Total Shareholder Return Amount, Dow Jones U.S. Health Care Index |
|
|
136.2
|
130.95
|
127.38
|
Net Income (Loss) |
|
|
$ 206,600,000
|
$ 201,700,000
|
$ 155,100,000
|
Company Selected Measure Amount | $ / shares |
|
|
2.42
|
2.09
|
1.91
|
PEO Name |
Mr. Walchirk
|
Mr. Zurbay
|
|
Mr. Walchirk
|
Mr. Walchirk
|
Measure [Axis]: 1 |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Measure Name |
|
|
Adjusted EPS
|
|
|
Non-GAAP Measure Description [Text Block] |
|
|
For each year disclosed in our Compensation Discussion and Analysis, adjusted earnings
per share is used in our long-term incentive program. Our Compensation and Human Capital Committee determined that this structure maintains management’s focus on execution while preserving a multi-year performance measurement period. The
committee believes this incentive framework is strongly aligned with shareholder interests and is consistent with shareholder feedback. Adjusted earnings per share is a non-GAAP financial metric. See the reconciliation of GAAP to non-GAAP
financial measures table, which appears as Annex A to this proxy statement, for further information regarding our adjusted financial metrics.
|
|
|
Measure [Axis]: 2 |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Compensation Actually Paid vs. Other Measure [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our adjusted operating income, our second company-selected measure, during fiscal years 2021 through 2023.
|
|
|
Measure Name |
|
|
Adjusted Operating Income
|
|
|
Non-GAAP Measure Description [Text Block] |
|
|
•
|
Adjusted Operating Income
|
For each year disclosed in our Compensation Discussion and Analysis, adjusted operating
income is used in our short-term incentive program. Our Compensation and Human Capital Committee determined that this structure drives performance and incentivizes management. The committee believes this incentive framework is strongly aligned
with shareholder interests and is consistent with shareholder feedback. Adjusted operating income is a non-GAAP financial metric. See the reconciliation of GAAP to non-GAAP financial measures table, which appears as Annex A to this proxy statement, for further information regarding our adjusted financial metrics.
|
|
|
Measure [Axis]: 3 |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Compensation Actually Paid vs. Other Measure [Text Block] |
|
|
Description of Pay Versus Performance
As described in Compensation Discussion and Analysis, a significant portion of annual
target compensation awarded to management is compensation at risk because it depends on the Company’s performance against pre-established performance goals under our MICP and LTIP, including stock price performance. The amounts reflected as
“Compensation Actually Paid” represent a new required calculation of compensation that differs from our Summary Compensation Table calculation of compensation, primarily regarding equity valuation. This “Compensation Actually Paid” calculation
methodology also differs from how the Compensation and Human Capital Committee views annual compensation decisions.
The following chart sets forth the relationship between PEO CAP, the average of other
NEOs CAP and our free cash flow, our third company-selected measure, during fiscal years 2021 through 2023.
|
|
|
Measure Name |
|
|
Free Cash Flow
|
|
|
Mr. Zurbay [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
PEO Total Compensation Amount |
|
|
$ 5,540,867
|
$ 0
|
$ 0
|
PEO Actually Paid Compensation Amount |
|
|
3,667,482
|
0
|
0
|
Mr. Walchirk [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
PEO Total Compensation Amount |
|
|
6,074,640
|
7,142,343
|
4,757,845
|
PEO Actually Paid Compensation Amount |
|
|
(7,551,398)
|
4,514,488
|
17,291,216
|
PEO [Member] | Mr. Zurbay [Member] | Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(3,889,123)
|
0
|
0
|
PEO [Member] | Mr. Zurbay [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
3,113,226
|
0
|
0
|
PEO [Member] | Mr. Zurbay [Member] | Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(1,062,922)
|
0
|
0
|
PEO [Member] | Mr. Zurbay [Member] | Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(34,566)
|
0
|
0
|
PEO [Member] | Mr. Zurbay [Member] | Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
0
|
0
|
0
|
PEO [Member] | Mr. Walchirk [Member] | Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(5,323,127)
|
(4,703,083)
|
(2,181,598)
|
PEO [Member] | Mr. Walchirk [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
0
|
4,366,883
|
6,938,194
|
PEO [Member] | Mr. Walchirk [Member] | Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
0
|
(1,798,226)
|
6,059,476
|
PEO [Member] | Mr. Walchirk [Member] | Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(107,722)
|
(493,429)
|
1,717,299
|
PEO [Member] | Mr. Walchirk [Member] | Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(8,195,189)
|
0
|
0
|
Non-PEO NEO [Member] | Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(723,144)
|
(852,067)
|
(402,747)
|
Non-PEO NEO [Member] | Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
438,869
|
791,512
|
1,279,702
|
Non-PEO NEO [Member] | Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(239,944)
|
(324,290)
|
1,564,227
|
Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years for Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
(12,003)
|
(55,589)
|
312,433
|
Non-PEO NEO [Member] | Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year [Member] |
|
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
Adjustment to Compensation Amount |
|
|
$ (209,614)
|
$ 0
|
$ 0
|